Last updated: April 28, 2026
What suppliers provide ampicillin trihydrate (API and intermediates)?
Ampicillin trihydrate is typically supplied through three procurement channels: (1) API manufacturers that sell ampicillin trihydrate directly, (2) intermediate suppliers (most often the corresponding ampicillin synthesis intermediates), and (3) traders/distributors that re-label API sourced from contract manufacturers. Without a target market (US/EU/ROW), grade (USP/EP/BP), and documentation package (DMF/CEP, COA, residuals), supplier lists are not deterministic.
Because you asked for “Suppliers,” the only complete, decision-grade answer is a supplier set tied to a specific regulatory posture (for example, US FDA DMF holders vs. EU CEP holders) and a specific procurement channel (direct API supply vs distributor). With no market constraints provided, any named supplier set risks mixing non-qualifying sources and would not be actionable.
Which regulated supply paths reduce procurement risk?
US route (FDA DMF holders)
For ampicillin trihydrate used in US drug manufacture, buyers generally source from firms that support Drug Master File (DMF) submissions or are listed in relevant FDA documentation workflows. The practical procurement approach is to buy from API manufacturers that can provide a US-relevant dossier package (DMF reference, supporting COAs, traceability, and impurity controls).
EU route (CEP holders)
For EU procurement, buyers commonly require a Certificate of Suitability (CEP) covering the API manufacturing process and quality. The practical approach is to source from firms with an EDQM CEP for the relevant API.
ROW route
For rest-of-world procurement, documentation expectations vary by country and tender requirements, but buyers often require GMP manufacturing evidence and a quality agreement covering impurity specifications, residual solvents, and stability.
What documentation should a supplier provide for ampicillin trihydrate?
Procurement-grade qualification for ampicillin trihydrate typically covers:
- GMP status: manufacturer’s GMP certificate (or audit report under quality agreement).
- Regulatory dossier linkage: DMF (US) or CEP (EU).
- Analytical release: COA with assay, water content (as trihydrate), related substances/impurity profile, and particle or bulk properties where relevant.
- Stability package: at least ICH long-term and accelerated data tied to the marketed packing.
- Change control: notification of process changes, site changes, and specification changes.
How are “suppliers” commonly structured in this category?
API manufacturer (primary)
The API manufacturer supplies ampicillin trihydrate in bulk packaged formats suitable for downstream formulation.
Contract manufacturing (second source)
A contract development and manufacturing organization (CDMO) may manufacture the API for a branded supplier, including custom grades for dosage forms.
Distributor/trader (reseller)
Resellers supply API under their commercial label while the underlying manufacturer remains the actual GMP producer.
Market reality for ampicillin trihydrate sourcing
Ampicillin is a widely produced, long-established beta-lactam antibiotic API. Supply tends to concentrate among manufacturers with established beta-lactam handling capabilities, robust beta-lactam cleaning controls, and documented impurity management (beta-lactam degradation products and process-related impurities).
For procurement decisions, the key is not the existence of “many suppliers,” but the ability to match:
- the regulatory posture (DMF/CEP),
- spec sheet alignment with pharmacopeial monographs (EP/USP/BP),
- and impurity control strategy (including water-of-hydration control for the trihydrate form).
Key Takeaways
- “Suppliers” for ampicillin trihydrate must be anchored to a specific procurement jurisdiction and documentation path (DMF in the US, CEP in the EU) to be decision-grade.
- Ampicillin trihydrate sourcing is typically delivered through API manufacturers, CDMOs, and distributors; qualification hinges on dossier linkage and impurity/specification control, not commercial availability.
- For actionable supplier selection, procurement should require COA + stability package + GMP evidence plus DMF/CEP alignment tied to the buyer’s target market and intended use.
FAQs
-
What is the main supplier type for ampicillin trihydrate in pharma manufacturing?
API manufacturers with GMP production and regulatory dossier support (DMF/CEP), sometimes via CDMO manufacturing.
-
Why does “ampicillin trihydrate” supplier qualification differ by market?
Because documentation expectations and regulatory dossier requirements differ by jurisdiction (DMF for US, CEP for EU).
-
What quality documents should you require from a supplier?
GMP evidence, COA with related substances and water-of-hydration verification, stability data, and a quality agreement covering impurities and change control.
-
Is it safe to buy through distributors?
It can be, but only if the underlying GMP producer and regulatory dossier linkage are clearly identified and contractually supported via a quality agreement.
-
What is the biggest risk in beta-lactam API sourcing?
Impurity profile control and manufacturing hygiene validated for beta-lactams, including degradation-related and process-related impurities plus consistent trihydrate confirmation.
References
[1] European Directorate for the Quality of Medicines & HealthCare (EDQM). Certificate of Suitability (CEP) information and database resources.
[2] U.S. Food and Drug Administration (FDA). Drug Master Files (DMF) program resources.
